BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Giandalia A, Giuffrida AE, Gembillo G, Cucinotta D, Squadrito G, Santoro D, Russo GT. Gender Differences in Diabetic Kidney Disease: Focus on Hormonal, Genetic and Clinical Factors. Int J Mol Sci 2021;22:5808. [PMID: 34071671 DOI: 10.3390/ijms22115808] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen Y, Wang X, Jia Y, Zou M, Zhen Z, Xue Y. Effect of a sodium restriction diet on albuminuria and blood pressure in diabetic kidney disease patients: a meta-analysis. Int Urol Nephrol 2021. [PMID: 34671892 DOI: 10.1007/s11255-021-03035-x] [Reference Citation Analysis]
2 Buades JM, Craver L, Del Pino MD, Prieto-Velasco M, Ruiz JC, Salgueira M, de Sequera P, Vega N. Management of Kidney Failure in Patients with Diabetes Mellitus: What Are the Best Options? J Clin Med 2021;10:2943. [PMID: 34209083 DOI: 10.3390/jcm10132943] [Reference Citation Analysis]
3 Gembillo G, Cernaro V, Giuffrida AE, Russo G, Giandalia A, Siligato R, Longhitano E, Santoro D. Gender differences in new hypoglycemic drug effects on renal outcomes: a systematic review. Expert Rev Clin Pharmacol 2022. [PMID: 35300556 DOI: 10.1080/17512433.2022.2055546] [Reference Citation Analysis]
4 Amatruda M, Gembillo G, Giuffrida AE, Santoro D, Conti G. The Aggressive Diabetic Kidney Disease in Youth-Onset Type 2 Diabetes: Pathogenetic Mechanisms and Potential Therapies. Medicina (Kaunas) 2021;57:868. [PMID: 34577791 DOI: 10.3390/medicina57090868] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kovesdy C, Schmedt N, Folkerts K, Bowrin K, Raad H, Batech M, Fried L. Predictors of cardio-kidney complications and treatment failure in patients with chronic kidney disease and type 2 diabetes treated with SGLT2 inhibitors. BMC Med 2022;20:2. [PMID: 35000594 DOI: 10.1186/s12916-021-02191-2] [Reference Citation Analysis]
6 Houeiss P, Njeim R, Tamim H, Hamdy AF, Azar TS, Azar WS, Noureldein M, Zeidan YH, Rashid A, Azar ST, Eid AA. Urinary 20-HETE: A prospective Non-Invasive prognostic and diagnostic marker for diabetic kidney disease. Journal of Advanced Research 2022. [DOI: 10.1016/j.jare.2022.04.013] [Reference Citation Analysis]
7 Wu M, Zhang M, Zhang Y, Li Z, Li X, Liu Z, Liu H, Li X. Relationship between lysosomal dyshomeostasis and progression of diabetic kidney disease. Cell Death Dis 2021;12:958. [PMID: 34663802 DOI: 10.1038/s41419-021-04271-w] [Reference Citation Analysis]
8 Gherghina ME, Peride I, Tiglis M, Neagu TP, Niculae A, Checherita IA. Uric Acid and Oxidative Stress-Relationship with Cardiovascular, Metabolic, and Renal Impairment. Int J Mol Sci 2022;23:3188. [PMID: 35328614 DOI: 10.3390/ijms23063188] [Reference Citation Analysis]
9 Tsai KY, Chen S, Chou CW, Tzeng TF, Lee YJ, Chen ML. Quality of care and prescription patterns among patients with diabetic kidney disease-a large-scale cohort study from Taiwanese clinics. PeerJ 2022;10:e13636. [PMID: 35915752 DOI: 10.7717/peerj.13636] [Reference Citation Analysis]
10 Gembillo G, Visconti L, Giuffrida AE, Labbozzetta V, Peritore L, Lipari A, Calabrese V, Piccoli GB, Torreggiani M, Siligato R, Santoro D. Role of Zinc in Diabetic Kidney Disease. Nutrients 2022;14:1353. [PMID: 35405968 DOI: 10.3390/nu14071353] [Reference Citation Analysis]
11 Liu W, Du J, Ge X, Jiang X, Peng W, Zhao N, Shen L, Xia L, Hu F, Huang S. The analysis of risk factors for diabetic kidney disease progression: a single-centre and cross-sectional experiment in Shanghai. BMJ Open 2022;12:e060238. [PMID: 35768116 DOI: 10.1136/bmjopen-2021-060238] [Reference Citation Analysis]
12 Gembillo G, Visconti L, Giusti MA, Siligato R, Gallo A, Santoro D, Mattina A. Cardiorenal Syndrome: New Pathways and Novel Biomarkers. Biomolecules 2021;11:1581. [PMID: 34827580 DOI: 10.3390/biom11111581] [Reference Citation Analysis]
13 Jin D, Liu F, Yu M, Zhao Y, Yan G, Xue J, Sun Y, Zhao D, Li X, Qi W, Wang X. Jiedu Tongluo Baoshen formula enhances podocyte autophagy and reduces proteinuria in diabetic kidney disease by inhibiting PI3K/Akt/mTOR signaling pathway. J Ethnopharmacol 2022;293:115246. [PMID: 35398500 DOI: 10.1016/j.jep.2022.115246] [Reference Citation Analysis]
14 Przybyciński J, Drożdżal S, Domański L, Dziedziejko V, Pawlik A. Role of Endothelial Glucocorticoid Receptor in the Pathogenesis of Kidney Diseases. Int J Mol Sci 2021;22:13295. [PMID: 34948091 DOI: 10.3390/ijms222413295] [Reference Citation Analysis]
15 Bianco A, Tiribelli C, Bellarosa C. Translational Approach to the Protective Effect of Bilirubin in Diabetic Kidney Disease. Biomedicines 2022;10:696. [DOI: 10.3390/biomedicines10030696] [Reference Citation Analysis]